IRODALOM
1. Blaj P., Astudillo A., Buesa JM. és mtsai: Protein kinase C theta is highly expressed in gastrointestinal stroma tumors but
not in other mesenchymal neoplasms. Clin. Cancer Res. 2004;10:4089-95.
2. Blanke CD.: Therapeutic options for gastrointestinal stomal tumors American Society of Clinical Oncology VA USA.
2003;266-72.
3. Blanke CD., Joensuu H., Demetri G és mtsai.: Long-term follow-up of advanced gastrointestinal stromal tumor (GIST)
patients treated with imastinib mesylate. Am. Soc. Clin. Oncol. Gastrointest. Cancer Symp. 2004; Abstract 2.
4. Debiec-Rychter M., Wasag B., Stul M. és mtsai.: Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117
antigen) immmunreactivity. J. Pathol. 2004;430-8.
5. Debiec-Rychter M., Dubez H., Judson I. és mtsai.: Use of c-KIT/PDGFRA mutational analysis to predict the clinical
response to imanitib in patients with advanced gastrointestinal stromal tumors entered on Phase I and II studies of the
EORTC Soft Tissue and Bone Sarcoma Group. Eur. J. Cancer. 2004;40:689-95.
6. Desai J., Maki R., Heinrich MC. és mtsai.: Activity and tolerability of the multitargeted tyrosine kinase inhibitor
SU011248 in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) refractory to imatinib mesylate. Am.
Soc. Clin. Oncol. Gastrointest. Cancer Symp. 2004;Abstr.7.
7. Hohenberger P., Bauer S., Schneider U. és mtsai.: Tumor resection following imanitib pretreatment in GI stromal tumors.
Proc. Am. Soc. Clin Oncol. Abstract 3288 (2003).
8. Koon N., Schneider Stock R., Sarlomo-Rikala M. és mtsai.: Molecular targets for tumour progression in gastrointestinal
stroma tumours. Gut. 2004;53:235-240.
9. Lasota J., Dansonka-Mieszkowska A., Sobin LH., Miettinen M.: A great majoritiy of GISTs with PDGFRA mutations
represent gastric tumors of low or no malignant potencial. Lab. Invest. 2004;84:874-83.
10. Medeiros F., Corless CL., Duensing A. és mtsai.: KIT-negative gastrointestinal stromal tumors: Proof of concept and
therapeutic implications. Am. J. Surg Pathol. 2004;28:889-94.
11. Tosoni A., Nicolardi L., Brandes A.: Current clinical management of gastrointestinal stomal tumors. Expert. Rev.
Anticancer Ther. 2004;4:595-605.
